VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 113 filers reported holding VERONA PHARMA PLC in Q1 2024. The put-call ratio across all filers is 1.06 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $413,426 | -7.2% | 28,591 | +3.2% | 0.00% | – |
| Q1 2024 | $445,613 | -12.7% | 27,695 | +7.9% | 0.00% | – |
| Q4 2023 | $510,320 | +13.2% | 25,670 | -7.2% | 0.00% | – |
| Q3 2023 | $450,662 | -13.5% | 27,648 | +12.1% | 0.00% | – |
| Q2 2023 | $521,270 | +17.1% | 24,658 | -55.5% | 0.00% | – |
| Q1 2023 | $444,986 | -33.9% | 55,411 | +115.2% | 0.00% | – |
| Q4 2022 | $672,952 | +307.8% | 25,754 | +59.1% | 0.00% | – |
| Q3 2022 | $165,000 | – | 16,192 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 901,943 | $3,716,000 | 2.47% |
| venBio Partners LLC | 456,770 | $1,882,000 | 1.60% |
| Aisling Capital Management LP | 443,596 | $1,828,000 | 0.80% |
| Vivo Capital, LLC | 1,492,951 | $6,151,000 | 0.56% |
| NEA Management Company, LLC | 1,219,674 | $5,025,000 | 0.26% |
| Novo Holdings A/S | 740,740 | $3,052,000 | 0.20% |
| Orbimed Advisors | 1,250,396 | $5,152,000 | 0.09% |
| Clear Creek Financial Management, LLC | 37,500 | $170,000 | 0.06% |
| Tekla Capital Management LLC | 253,179 | $1,043,000 | 0.05% |
| WEDBUSH SECURITIES INC | 70,950 | $292,000 | 0.04% |